Amrize AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AMRZ research report →
Range $32 – $63
Price Chart
About the company
Amrize AG engages in the provision of various building solutions for infrastructure, commercial, and residential construction markets in North America and Canada. It operates through two segments, Building Materials and Building Envelope. The Building Materials segment offers cement and aggregates, as well as ready-mix concrete, asphalt, and other construction materials.
- CEO
- Jan Philipp Jenisch
- IPO
- 2025
- Employees
- 19,000
- HQ
- Zug, CH
AI snapshot
Six angles, distilled from the data.
AMRZ is still in a corrective regime after a sharp pullback from its 52-week high, but the stock has stabilized well above the 50-day average and remains far below the 200-day trend line. That leaves it in a rebound phase, not a confirmed long-term trend reversal.
Street sentiment is cautious: the consensus sits at Hold with 4 Buys, 6 Holds, and 2 Sells. The average target is around $45.78, modestly above the last close, but recent action has skewed negative with multiple target cuts and Jefferies moving to Cautious/Underperform.
The earnings profile is mixed but improving at the margin. AMRZ has beaten EPS in 2 of the last 6 quarters, and next-year EPS estimates point to $2.51 from $2.23 TTM. Shareholders should watch whether the recent beat at $1.02 versus $0.98 can carry into margin and guidance commentary.
Insider activity is a clear positive, with 14 buys and no sells. The strongest signal is discretionary buying from the Chairman & CEO, alongside purchases from multiple officers and directors, which points to broad internal confidence rather than isolated activity.
Profitability is solid for a materials name, with a 24.8% gross margin, 15.7% operating margin, and 10.2% net margin. Growth is modest but positive, with revenue up 2.2% year over year and earnings up 4.1%, while free cash flow of $3.00 billion supports the business.
AMRZ looks cheaper than many growth-oriented industrial peers on cash generation, with a 13.93% free-cash-flow yield and a 17.25 P/E. The tradeoff is leverage: $5.91 billion of debt versus $1.92 billion of cash leaves a meaningful net debt load.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $21.36B
- Fwd P/E
- 16.70
- Div Yield
- 1.80%
Latest fiscal year · YoY change
- Revenue
- $11.81B+0.9%
- Gross Profit
- $3.03B-1.2%
- Op Income
- $1.91B
- Net Income
- $1.19B-7.0%
- EPS
- $2.14-7.0%
- OCF Growth
- -3.2%
- FCF Growth
- -13.4%
- 52W High
- $65.94
- 52W Low
- $35.78
- 50D MA
- $39.16
- 200D MA
- $49.60
- Beta
- -0.03
- RSI (14)
- 42
- Avg Volume
- 4.08M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Amrize delivered modest Q3 growth on pricing and acquisitions, while weather and inflation pressured volumes and Building Envelope profitability, leading the company to raise its 2026 revenue and EBITDA outlook.· October 29, 2026
- Revenue rose 2.2% year over year on stronger pricing and acquisition contributions; net income increased 3.3% to $558 million and diluted EPS rose 4.1% to $1.02.
- Adjusted EBITDA increased to $1.1 billion, with Building Materials margin up 30 basis points, helped by cement and aggregates pricing plus ASPIRE savings.
- Building Materials showed solid pricing momentum: cement pricing was up 1.8% and aggregates pricing up 6.9%, while volumes were hurt by weather.
- Building Envelope had better commercial roofing demand but weaker residential roofing, with adjusted EBITDA down 14.6% year over year as raw materials and freight inflation hit margins.
- Management raised full-year 2026 guidance to revenue of $12.2 billion-$12.4 billion and EBITDA of $2.95 billion-$3.05 billion, citing stronger-than-expected pricing and cost actions but also a $36 million insurance benefit that will not repeat.
Q3 2026 revenue increased 2.2% year over year. Net income rose 3.3% to $558 million, adjusted EBITDA increased to $1.1 billion, and diluted EPS grew 4.1% to $1.02. Building Materials revenue increased 1.8% year over year to $2.8 billion, with Building Materials adjusted EBITDA up 2.7% to $938 million; Building Envelope revenue increased 3.6% to $929 million, while Building Envelope adjusted EBITDA fell 14.6% year over year. Pricing contributed a $78 million tailwind in the quarter, surcharges added $23 million, volumes were a $69 million headwind, and PB Materials plus Rapid Redi-Mix contributed $77 million of revenue. Full-year 2026 guidance was raised to revenue of $12.2 billion-$12.4 billion and EBITDA of $2.95 billion-$3.05 billion. Management expects cement pricing to be flat to low single digit for the full year, aggregates pricing to be mid-single digit, Building Materials to be price-over-cost positive in Q4, and Building Envelope price-over-cost positivity to shift into 2027.
Jan Jenisch emphasized that the quarter showed the resilience of Amrize’s network, with pricing, acquisitions and ASPIRE offsetting weather-related volume pressure and inflation. He repeatedly highlighted mega-project demand in data centers, energy, infrastructure and manufacturing as the long-term growth engine, and said the company is well positioned with its North American footprint and domestic supply chains. His tone was confident on controllable items like pricing, surcharges, CapEx and M&A, while acknowledging that inflation and interest rates are harder to predict.
Sam Poletti said revenue growth was driven by pricing and M&A, with price contributing a $78 million tailwind and surcharges adding $23 million, while weather-affected volumes were a $69 million headwind. He noted Building Materials EBITDA improved from pricing actions and acquisition contributions, partially offset by freight, diesel and raw material inflation, and that ASPIRE helped keep the company in a positive price-over-cost position at the consolidated level. On liquidity, he cited net leverage of 1.8x, about $299 million of cash and cash equivalents, and $3.4 billion of total available liquidity, and said cash conversion will be lower than the 50% midterm target because the company is investing more in the business.
Analysts focused on whether pricing can keep up with inflation into 2027, especially in Building Envelope, and management said it expects 2027 to be a growth year but cannot forecast how inflation will evolve. They also asked about price-over-cost timing in Building Envelope; Jenisch said the business is still dealing with petrochemical-based raw material inflation and softer residential roofing demand, but pricing and surcharges are improving and should continue into 2027. Questions on M&A drew a confident response that the pipeline remains solid, with recent bolt-ons PB Materials and Rapid Redi-Mix outperforming expectations and adding more than 2% to sales and EBITDA growth. On cement imports, Jenisch said Amrize’s strategy is local supply chains, not imports, and that the company had almost no cement imports this year.
The company is showing that it can still grow revenue and margins even with weather disruptions and inflation, thanks to pricing discipline, surcharges and ASPIRE savings. Management sees durable demand from mega-projects, infrastructure, data centers and industrial onshoring, and recent acquisitions are already contributing above expectations.
Volume trends were soft in the quarter, with weather hurting Building Materials and residential roofing remaining pressured by weak home sales, lack of storms and destocking. Inflation in freight, diesel and raw materials is still outrunning price in parts of Building Envelope, pushing price-over-cost positivity there into 2027 and limiting near-term margin recovery.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 86.3%
- Shares Outstanding
- 546.93M
- Float Shares
- 472.02M
of shares held by institutions
487 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for AMRZ, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 31.77M | ▲ 1.68M |
| Vanguard Capital Management LLC | 22.58M | ▲ 1.25M |
| Harris Associates L P | 15.99M | ▲ 2.00M |
| Blackrock, Inc. | 15.78M | ▼ 387.89K |
| Invesco Ltd. | 14.63M | ▲ 6.04M |
| Norges Bank | 14.07M | ▲ 14.07M |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 9.86M | ▼ 987.49K |
| Vanguard Fiduciary Trust Co | 7.77M | ▲ 423.59K |
| Ubs Group AG | 7.35M | ▼ 913.43K |
| Geode Capital Management, LLC | 6.87M | ▲ 665.50K |
| Pictet Asset Management Holding SA | 6.13M | ▲ 253.51K |
| State Street Corp | 5.69M | ▲ 422.96K |
Held by 322 ETFs
Biggest fund positions in AMRZ by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 1, 26 | Nielsen Zane Michael | other | 0 |
| Sep 2, 26 | Jenisch Jan Philipp | buy | 1,000 |
| Sep 2, 26 | Jenisch Jan Philipp | buy | 15,000 |
| Sep 2, 26 | Jenisch Jan Philipp | buy | 10,000 |
| Sep 2, 26 | Jenisch Jan Philipp | buy | 2,000 |
| Sep 2, 26 | Jenisch Jan Philipp | buy | 2,000 |
| Aug 27, 26 | Gibson Dwight Audley Konrad | buy | 5.47 |
| Aug 26, 26 | Sanche Jacques Wolf | buy | 4,150 |
| Aug 25, 26 | Singleton Denise R | buy | 3,500 |
| Aug 25, 26 | Forrest Nollaig | buy | 1,500 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our AMRZ coverage
Recent articles, reports, and earnings notes.

Amrize Ltd. (AMRZ): Growth Case Tempered by Cyclicality
Amrize has a credible North American growth story tied to data centers and infrastructure, but execution risk and cyclical pressure keep the stock at Hold. Q3 showed solid revenue and cash generation, yet earnings momentum remains uneven.

Amrize AG (AMRZ) slips as earnings depth disappoints
Amrize AG (AMRZ) slips after a modest earnings miss, but the deeper story is softer volume, thinner margins, and weakening cash conversion. Pricing helped offset some pressure, yet adjusted EBITDA barely grew and free cash flow remained negative, tempering the case for a quick rebound.

Amrize AG (AMRZ) slips as earnings misses weigh on shares
Amrize AG (AMRZ) slips 0.5% after reporting earnings misses, with investors reacting to weaker-than-expected results and pressure on the stock.
Want a deeper read on AMRZ?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
New Strong Sell Stocks for November 17th
zacks.com · Nov 17
Stock Picks From Seeking Alpha's October 2026 New Analysts
seekingalpha.com · Nov 6
Amrize Expands ‘Made in Canada' Cement Label for Canadian Builders
businesswire.com · Nov 4
What Amrize (AMRZ) Said on Its Q3 Earnings Call
marketbeat.com · Oct 30
Amrize: 3 Key Takeaways for Long-Term Investors
fool.com · Oct 29
Amrize AG (AMRZ) Q3 2026 Earnings Call Transcript
seekingalpha.com · Oct 29
Amrize Ltd (AMRZ) Q3 Earnings Surpass Estimates
zacks.com · Oct 28
Amrize Ltd (AMRZ) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com · Oct 28
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed November 20, 2026 · Live quote · Not investment advice